Where does GI Bionics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GI Bionics, LLC ranks #40,422 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GI Bionics, LLC hold?

GI Bionics, LLC holds 6 US utility patents granted between 2021 and 2023, spanning 3 technology areas.

What is GI Bionics, LLC's Innovation Score?

GI Bionics, LLC has an Innovation Score of 34.7 out of 100 (48th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GI Bionics, LLC focus on?

GI Bionics, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents, ranking #2,680 of 7,127 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is GI Bionics, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for GI Bionics, LLC.

What does claim depth mean for GI Bionics, LLC's patents?

GI Bionics, LLC's patents average 14.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GI Bionics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

GI Bionics, LLC

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, GI ranks #40,422 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#40,422
of 49,997 US assignees by volume: 48th percentile
by Innovation Score (34.7/100): 14.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R40422 · US Corporation #40,422 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #40,422/49,997
PHOTO-FINISH GFI Group
CPC-NARROW A61B · 3 areas
INNOV-THIN 34.7/100
CLAIMS-RICH 14.2 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: GFI Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How GI’s 34.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (19%) Velocity 13.3 pts (38%) Breadth 6.1 pts (18%) Claim depth 8.5 pts (25%)

Qualcomm Incorporated · highest

85
Freudenberg Medical · near

35
GI Bionics · this assignee

35
HCA Holdings · near

35
Satori Worldwide · near

35
Woongjin Coway · near

35
3D Lighting… · lowest

7

What this shows GI's Innovation Score is 34.7/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for GI?

Each dot is one of GI’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). GI’s own 14.2 claims/patent is ABOVE the 8.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

GI vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where GI's grants concentrate

GI Bionics, LLC is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2022. By volume, GI sits between GFI Group, Inc. and Gim-hwa Enterprise Co., Ltd..

GI's three-year grant acceleration

GI Bionics, LLC shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

GFI Group

6
Ggumbi

6
Gharda Chemicals

6
GHP Group

6
GI Scientific

6
Gibraltar Global

6
Gigacloud Technol…

6
Gim-hwa Enterprise

6
GI Bionics ◀

6

What this shows GI holds 6 patents at rank #40,385, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GI

By rank, the assignees closest to #40,385 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in GI's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for GI, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), GI ranks #2,680 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Freudenberg Medical, LLC 35 Satori Worldwide, LLC 35 HCA Holdings, Inc. 35 Woongjin Coway Co., Ltd. 35

GI's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

GI Bionics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	33.3%
2022	1	16.7%
2023	3	50.0%

Which technologies does GI Bionics, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GI Bionics, LLC's patent record in context - here's where to go next.

GI Bionics, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #40,422 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GI Bionics, LLC against GFI Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.